The Hospital Universitario La Paz, HULP, is a general tertiary hospital situated in the neighbourhood that takes its name from the hospital in the northern city district of Fuencarral-El Pardo in the city of Madrid in Spain.

There are 1,308 beds in Hospital Universitario La Paz; Servicio de Oncologia.

During the past decade, Hospital Universitario La Paz; Servicio de Oncologia conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 25 clinical trials were completed, i.e. on average, 65.8% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 13 clinical trials were completed. i.e. 92.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario La Paz; Servicio de Oncologia" #1 sponsor was "Hoffmann-La Roche" with 49 trials, followed by "Institut de Recherches Internationales Servier" with 2 trials sponsored, "CytomX Therapeutics" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario La Paz; Servicio de Oncologia" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Exelixis" with 2 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario La Paz; Servicio de Oncologia" are "Breast Cancer" (6 trials), "Non-Small Cell Lung Cancer" (5 trials), "Ovarian Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Hospital Universitario La Paz; Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital Universitario La Paz; Servicio de Oncologia" are "Drug" (53 trials), "Other" (3 trials), "Biological" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (25 trials), "Bevacizumab" (10 trials), "Placebo" (10 trials), "Carboplatin" (8 trials) and "Docetaxel" (8 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario La Paz; Servicio de Oncologia" are 48 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Universitario La Paz; Servicio de Oncologia". undefined are not yet recruiting, 9 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Hospital Universitario La Paz; Servicio de Oncologia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario La Paz; Servicio de Oncologia, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".